Shares of the learning services provider are falling as technology advancements threaten its revenue.
1 extracted signal · 1 resolved · 0 still active
Parkev Tatevosian, CFA19 Sept 2025, 17:45 UTC
AI-generated source summary
The video provides a fundamental analysis of Duolingo (DUOL) stock, currently priced at $279.16. It notes that the stock has fallen from around $550 in May. The analyst mentions that Duolingo's revenue has grown from $100 million in 2019 to $900 million, representing a 58.3% compound annual growth rate, however is concerned about new technologies that could reduce the demand for language learning. The analyst discusses the increasing trade barriers. Analyst rates DUOL stock with Hold, calculating intrinsic value per share is $315.10 and has been rated based on the report from April 21th
AI-generated summary based on the source content.
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
Signals in this source
More Prediction Case Files from Parkev Tatevosian, CFA
Coca-Cola Stock: Buy, Hold, or Sell? | KO Stock Analysis
SoFi Stock Analysis: Buy the Dip?
Should You Buy Micron Stock Instead of Nvidia Stock? | MU Stock vs. NVDA Stock
Should You Buy the Dip in Meta Stock? | META Stock Analysis and Live Earnings Review
Should Passive Income Investors Buy Colgate Palmolive Stock?
Procter & Gamble Stock: Buy, Hold, or Sell? | PG Stock Analysis
Parkev Tatevosian, CFA
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.